{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T20:10:02Z","timestamp":1745698202077,"version":"3.40.4"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.phrs.2025.107718","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T07:24:03Z","timestamp":1743233043000},"page":"107718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IUPHAR review: Computational Psychiatry 2.0. A new tool for supporting combination therapy of psychopharmacology with neuromodulation in schizophrenia"],"prefix":"10.1016","volume":"215","author":[{"given":"Hugo","family":"Geerts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107718_bib1","unstructured":"Abbvie. (n.d.). Abbvie provides update on Phase 2 results for emraclidine in schizophrenia. Https:\/\/News.Abbvie.Com\/2024-11-11-Abbvie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia."},{"issue":"10","key":"10.1016\/j.phrs.2025.107718_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.biopsych.2004.01.018","article-title":"Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide","volume":"55","author":"Abi-Dargham","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2025.107718_bib3","first-page":"404","article-title":"Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia","volume":"9","author":"Abi-Dargham","year":"2003","journal-title":"Neurosci.: A Rev. J. Bringing Neurobiol., Neurol. Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2025.107718_bib4","first-page":"390","article-title":"Research progress on phosphodiesterase 4 inhibitors in central nervous system diseases","volume":"53","author":"Adili","year":"2024","journal-title":"Zhejiang Da Xue Xue Bao. Yi Xue Ban. =\u2009J. Zhejiang Univ. Med. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2025.107718_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.9758\/cpn.2017.15.2.115","article-title":"In silicomodel-driven assessment of the effects of brain-derived neurotrophic factor deficiency on glutamate and gamma-aminobutyric acid: implications for understanding schizophrenia pathophysiology","volume":"15","author":"Agrawal","year":"2017","journal-title":"Clin. Psychopharmacol. Neurosci.: Off. Sci. J. Korean Coll. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107718_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.psc.2016.04.004","article-title":"Adverse effects of electroconvulsive therapy","volume":"39","author":"Andrade","year":"2016","journal-title":"Psychiatr. Clin. North Am."},{"issue":"5400","key":"10.1016\/j.phrs.2025.107718_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.283.5400.381","article-title":"Emergent properties of networks of biological signaling pathways","volume":"283","author":"Bhalla","year":"1999","journal-title":"Sci. (N. Y., N. Y. )"},{"issue":"1\u20133","key":"10.1016\/j.phrs.2025.107718_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.schres.2014.06.005","article-title":"Metacognitive training for schizophrenia: a multicentre randomised controlled trial","volume":"157","author":"Briki","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.phrs.2025.107718_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.schres.2023.12.017","article-title":"Temporal hyper-connectivity and frontal hypo-connectivity within gamma band in schizophrenia: a resting state EEG study","volume":"264","author":"Chang","year":"2024","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.phrs.2025.107718_bib10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/appi.ajp.2020.20101481","article-title":"Fifty years of research on schizophrenia: the ascendance of the glutamatergic synapse","volume":"177","author":"Coyle","year":"2020","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2025.107718_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/cogs.12613","article-title":"Generalized information theory meets human cognition: introducing a unified framework to model uncertainty and information search","volume":"42","author":"Crupi","year":"2018","journal-title":"Cogn. Sci."},{"key":"10.1016\/j.phrs.2025.107718_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpsychires.2023.11.036","article-title":"The noise in our brain: a systematic review and meta-analysis of neuroimaging and signal-detection studies on source monitoring in psychosis","volume":"169","author":"Damiani","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.phrs.2025.107718_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103250","article-title":"Physiological synchronization and entropy as measures of team cognitive load","volume":"96","author":"Dias","year":"2019","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.phrs.2025.107718_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109175","article-title":"Personalized whole brain modeling of status epilepticus","volume":"142","author":"Dollomaja","year":"2023","journal-title":"Epilepsy Behav.: EB"},{"key":"10.1016\/j.phrs.2025.107718_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.euroneuro.2024.04.007","article-title":"Single-arm meta-analysis of drug response in placebo-controlled versus active-controlled antipsychotic drug trials in schizophrenia","volume":"84","author":"Dong","year":"2024","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2025.107718_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/YCT.0000000000001095","article-title":"Use of cholinesterase inhibitors for treatment and prevention of cognitive adverse effects of electroconvulsive therapy: a systematic review","author":"Dylewski","year":"2024","journal-title":"J. ECT"},{"issue":"2","key":"10.1016\/j.phrs.2025.107718_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S2215-0366(23)00366-8","article-title":"Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data","volume":"11","author":"Efthimiou","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.phrs.2025.107718_bib18","article-title":"An in-depth analysis of parameter settings and probability distributions of specific ordinal patterns in the Shannon permutation entropy during different states of consciousness in humans","author":"Franka","year":"2023","journal-title":"J. Clin. Monit. Comput."},{"issue":"7","key":"10.1016\/j.phrs.2025.107718_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF02988639","article-title":"Neuroreceptor imaging in psychiatric disorders","volume":"16","author":"Frankle","year":"2002","journal-title":"Ann. Nucl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2025.107718_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/10601333.2015.980944","article-title":"Regulatory Considerations for the Clinical and Research Use of Transcranial Direct Current Stimulation (tDCS): review and recommendations from an expert panel","volume":"32","author":"Fregni","year":"2015","journal-title":"Clin. Res. Regul. Aff."},{"issue":"1","key":"10.1016\/j.phrs.2025.107718_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41380-022-01743-z","article-title":"Computational psychiatry: from synapses to sentience","volume":"28","author":"Friston","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107718_bib22","article-title":"Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases","author":"Geerts","year":"2023","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"S24","key":"10.1016\/j.phrs.2025.107718_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/alz.082487","article-title":"Exploring treatment guidelines for amyloid therapies in Alzheimer\u2019s Disease Using Predictive Quantitative System Pharmacology Modeling","volume":"19","author":"Geerts","year":"2023","journal-title":"Alzheimer\u2019S. Dement."},{"issue":"16","key":"10.1016\/j.phrs.2025.107718_bib24","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.4155\/fmc.14.97","article-title":"Multitarget drug discovery projects in CNS diseases: quantitative systems pharmacology as a possible path forward","volume":"6","author":"Geerts","year":"2014","journal-title":"Future Med. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2025.107718_bib25","article-title":"A quantitative system pharmacology computer model for cognitive deficits in schizophrenia","volume":"2","author":"Geerts","year":"2013","journal-title":"CPT: Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107718_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.euroneuro.2021.04.001","article-title":"Exploring the relation between BOLD fMRI and cognitive performance using a computer-based quantitative systems pharmacology model: Applications to the COMTVAL158MET genotype and ketamine","volume":"50","author":"Geerts","year":"2021","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107718_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/09540261.2017.1305949","article-title":"The development and modelling of devices and paradigms for transcranial magnetic stimulation","volume":"29","author":"Goetz","year":"2017","journal-title":"Int. Rev. Psychiatry (Abingdon, Engl. )"},{"issue":"S2","key":"10.1016\/j.phrs.2025.107718_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/alz.087647","article-title":"Exploring biological response profiles to amyloid antibodies in clinical practice using quantitative systems pharmacology","volume":"20","author":"Grant A","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"issue":"8","key":"10.1016\/j.phrs.2025.107718_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0306422","article-title":"Neurocognitive effects of 3 mA prefrontal electrical stimulation in schizophrenia: a randomized sham-controlled tDCS-fMRI study protocol","volume":"19","author":"Hallajian","year":"2024","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.phrs.2025.107718_bib30","first-page":"1240","article-title":"Disruptions of hierarchical cortical organization in early psychosis and schizophrenia","volume":"8","author":"Holmes","year":"2023","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"issue":"1\u20133","key":"10.1016\/j.phrs.2025.107718_bib31","first-page":"19","article-title":"Current and emerging technologies to address the placebo response challenge in CNS clinical trials: promise, pitfalls, and pathways forward","volume":"21","author":"Horan","year":"2024","journal-title":"Innov. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107718_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41398-024-02994-w","article-title":"Effect of transcranial direct current stimulation with concurrent cognitive performance targeting posterior parietal cortex vs prefrontal cortex on working memory in schizophrenia: a randomized clinical trial","volume":"14","author":"Hou","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2025.107718_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41386-020-0746-4","article-title":"Advances in the computational understanding of mental illness","volume":"46","author":"Huys","year":"2021","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107718_bib34","first-page":"37","article-title":"Exploring functional dysconnectivity in schizophrenia: alterations in eigenvector centrality mapping and insights into related genes from transcriptional profiles","volume":"10","author":"Ji","year":"2024","journal-title":"Schizophr. (Heidelb., Ger. )"},{"issue":"9","key":"10.1016\/j.phrs.2025.107718_bib35","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1176\/appi.ajp.2020.20081212","article-title":"Anticholinergic medication burden-associated cognitive impairment in schizophrenia","volume":"178","author":"Joshi","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"10422","key":"10.1016\/j.phrs.2025.107718_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0140-6736(23)02190-6","article-title":"Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial","volume":"403","author":"Kaul","year":"2024","journal-title":"Lancet (Lond., Engl. )"},{"issue":"2","key":"10.1016\/j.phrs.2025.107718_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000691","article-title":"Temporal sensitivity of protein kinase a activation in late-phase long term potentiation","volume":"6","author":"Kim","year":"2010","journal-title":"PLoS Comput. Biol."},{"issue":"10","key":"10.1016\/j.phrs.2025.107718_bib38","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.biopsych.2017.01.004","article-title":"Impaired tuning of neural ensembles and the pathophysiology of schizophrenia: a translational and computational neuroscience perspective","volume":"81","author":"Krystal","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2025.107718_bib39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/schbul\/sbx025","article-title":"Computational psychiatry and the challenge of schizophrenia","volume":"43","author":"Krystal","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.phrs.2025.107718_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.120403","article-title":"The virtual aging brain: causal inference supports interhemispheric dedifferentiation in healthy aging","volume":"283","author":"Lavanga","year":"2023","journal-title":"NeuroImage"},{"issue":"4","key":"10.1016\/j.phrs.2025.107718_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00023210-200418040-00005","article-title":"Dopamine partial agonists: a new class of antipsychotic","volume":"18","author":"Lieberman","year":"2004","journal-title":"CNS Drugs"},{"year":"2024","series-title":"Modified Titration of Donanemab Demonstrated Reduction of ARIA-E","author":"Lilly","key":"10.1016\/j.phrs.2025.107718_bib42"},{"issue":"1","key":"10.1016\/j.phrs.2025.107718_bib43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/15500594241238294","article-title":"Computational synaptic modeling of pitch and duration mismatch negativity in first-episode psychosis reveals selective dysfunction of the N-Methyl-D-aspartate receptor","volume":"56","author":"L\u00f3pez-Caballero","year":"2025","journal-title":"Clin. EEG Neurosci."},{"key":"10.1016\/j.phrs.2025.107718_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clinph.2024.07.006","article-title":"Transcranial direct current stimulation improves tardive dyskinesia in long-term hospitalized patients with chronic schizophrenia","volume":"166","author":"Lyu","year":"2024","journal-title":"Clin. Neurophysiol.: Off. J. Int. Fed. Clin. Neurophysiol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107718_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.biopsych.2011.02.031","article-title":"Transcranial magnetic stimulation: a neuroscientific probe of cortical function in schizophrenia","volume":"70","author":"McClintock","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2025.107718_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nn804","article-title":"Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia","volume":"5","author":"Meyer-Lindenberg","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2025.107718_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1204134","article-title":"Virtual brain simulations reveal network-specific parameters in neurodegenerative dementias","volume":"15","author":"Monteverdi","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.phrs.2025.107718_bib48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.schres.2024.06.036","article-title":"Targeting the superior temporal gyrus with real-time fMRI neurofeedback: A pilot study of the indirect effects on self-referential processes in schizophrenia","volume":"270","author":"Morfini","year":"2024","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.phrs.2025.107718_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000670","article-title":"A kinetic model of dopamine- and calcium-dependent striatal synaptic plasticity","volume":"6","author":"Nakano","year":"2010","journal-title":"PLoS Comput. Biol."},{"issue":"12","key":"10.1016\/j.phrs.2025.107718_bib50","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/bies.1154","article-title":"Modeling of signaling networks","volume":"24","author":"Neves","year":"2002","journal-title":"Bioessay.: N. Rev. Mol., Cell. Dev. Biol."},{"key":"10.1016\/j.phrs.2025.107718_bib51","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51214","article-title":"Human Neocortical Neurosolver (HNN), a new software tool for interpreting the cellular and network origin of human MEG\/EEG data","volume":"9","author":"Neymotin","year":"2020","journal-title":"ELife"},{"issue":"2","key":"10.1016\/j.phrs.2025.107718_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002383","article-title":"Subcellular location of PKA controls striatal plasticity: stochastic simulations in spiny dendrites","volume":"8","author":"Oliveira","year":"2012","journal-title":"PLoS Comput. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2025.107718_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011725","article-title":"The role of type 4 phosphodiesterases in generating microdomains of cAMP: large scale stochastic simulations","volume":"5","author":"Oliveira","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2025.107718_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104568","article-title":"Dopamine partial agonists and prodopaminergic drugs for schizophrenia: Systematic review and meta-analysis of randomized controlled trials","volume":"135","author":"Osugo","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2025.107718_bib55","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","article-title":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease","volume":"30","author":"Pagano","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2025.107718_bib56","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jsg.2005.01.016","article-title":"Flow perturbations","volume":"27","author":"Passchier","year":"2005","journal-title":"J. Struct. Geol."},{"key":"10.1016\/j.phrs.2025.107718_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clinph.2024.04.003","article-title":"Altered spreading of fast aperiodic brain waves relates to disease duration in Amyotrophic Lateral Sclerosis","volume":"163","author":"Polverino","year":"2024","journal-title":"Clin. Neurophysiol.: Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"10.1016\/j.phrs.2025.107718_bib58","article-title":"Enabling Electric Field Model of Microscopically Realistic Brain","author":"Qi","year":"2024","journal-title":"Brain Stimul."},{"key":"10.1016\/j.phrs.2025.107718_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.neunet.2017.07.016","article-title":"Entropy factor for randomness quantification in neuronal data","volume":"95","author":"Rajdl","year":"2017","journal-title":"Neural Netw."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2025.107718_bib60","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-008-1273-x","article-title":"Selective phosphodiesterase inhibitors: a promising target for cognition enhancement","volume":"202","author":"Reneerkens","year":"2009","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.phrs.2025.107718_bib61","article-title":"Simulations of symptomatic treatments for Alzheimer\u2019s disease: Computational analysis of pathology and mechanisms of drug action","volume":"4","author":"Roberts","year":"2012","journal-title":"Alzheimer\u2019S. Res. Ther."},{"key":"10.1016\/j.phrs.2025.107718_bib62","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fphar.2016.00006","article-title":"A humanized clinically calibrated quantitative systems pharmacology model for hypokinetic motor symptoms in Parkinson\u2019s disease","volume":"7","author":"Roberts","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107718_bib63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clinph.2020.10.003","article-title":"Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines","volume":"132","author":"Rossi","year":"2021","journal-title":"Clin. Neurophysiol.: Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"10.1016\/j.phrs.2025.107718_bib64","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pnpbp.2018.10.006","article-title":"The Dynamic Duo: Combining noninvasive brain stimulation with cognitive interventions","volume":"89","author":"Sathappan","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.phrs.2025.107718_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055762","article-title":"Transfer functions for protein signal transduction: application to a model of striatal neural plasticity","volume":"8","author":"Scheler","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2025.107718_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2024.103625","article-title":"BOLD signal variability as potential new biomarker of functional neurological disorders","volume":"43","author":"Schneider","year":"2024","journal-title":"NeuroImage. Clin."},{"issue":"1","key":"10.1016\/j.phrs.2025.107718_bib67","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.4637-10.2011","article-title":"Information capacity and transmission are maximized in balanced cortical networks with neuronal avalanches","volume":"31","author":"Shew","year":"2011","journal-title":"J. Neurosci."},{"issue":"S1","key":"10.1016\/j.phrs.2025.107718_bib68","article-title":"The Effect of modulating alpha-synuclein pathology on clinical Outcome in the presence of standard-of-care dopaminergic therapy in Parkinson\u2019s Disease: A QSP study","volume":"39","author":"Short S","year":"2024","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2025.107718_bib69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jtbi.2014.07.006","article-title":"Simulations suggest pharmacological methods for rescuing long-term potentiation","volume":"360","author":"Smolen","year":"2014","journal-title":"J. Theor. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107718_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.08.008","article-title":"Pathogenic Tau Impairs Axon Initial Segment Plasticity and Excitability Homeostasis","volume":"104","author":"Sohn","year":"2019","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.phrs.2025.107718_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110101","article-title":"The virtual multiple sclerosis patient","volume":"27","author":"Sorrentino","year":"2024","journal-title":"IScience"},{"key":"10.1016\/j.phrs.2025.107718_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2018.01.066","article-title":"On information metrics for spatial coding","volume":"375","author":"Souza","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107718_bib73","first-page":"589","article-title":"Not all partial dopamine D(2) receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse","volume":"6","author":"Spiros","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.phrs.2025.107718_bib74","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fphar.2014.00229","article-title":"A computer-based quantitative systems pharmacology model of negative symptoms in schizophrenia: exploring glycine modulation of excitation-inhibition balance","volume":"5","author":"Spiros","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107718_bib75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.euroneuro.2016.12.006","article-title":"Semi-mechanistic computer simulation of psychotic symptoms in schizophrenia with a model of a humanized cortico-striatal-thalamocortical loop","volume":"27","author":"Spiros","year":"2017","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2025.107718_bib76","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbae080","article-title":"Cognitive behavioral psychotherapy as an add-on in comprehensive outpatient care of non-affective psychoses: a multicenter randomized-controlled effectiveness trial in a naturalistic setting","author":"Steuwe","year":"2024","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.phrs.2025.107718_bib77","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jamapsychiatry.2014.163","article-title":"Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study","volume":"71","author":"Umbricht","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2025.107718_bib78","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwae079","article-title":"Virtual brain twins: from basic neuroscience to clinical use","volume":"11","author":"Wang","year":"2024","journal-title":"Natl. Sci. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2025.107718_bib79","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1037\/bne0000512","article-title":"Quantifying the inverted U: a meta-analysis of prefrontal dopamine, D1 receptors, and working memory","volume":"136","author":"Weber","year":"2022","journal-title":"Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2025.107718_bib80","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1037\/bne0000512","article-title":"Quantifying the inverted U: a meta-analysis of prefrontal dopamine, D1 receptors, and working memory","volume":"136","author":"Weber","year":"2022","journal-title":"Behav. Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107718_bib81","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1388-2457(99)00059-0","article-title":"Cortical activation, signal-to-noise ratio and stochastic resonance during information processing in man","volume":"110","author":"Winterer","year":"1999","journal-title":"Clin. Neurophysiol.: Off. J. Int. Fed. Clin. Neurophysiol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107718_bib82","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1388-2457(99)00322-3","article-title":"Schizophrenia: reduced signal-to-noise ratio and impaired phase-locking during information processing","volume":"111","author":"Winterer","year":"2000","journal-title":"Clin. Neurophysiol.: Off. J. Int. Fed. Clin. Neurophysiol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107718_bib83","article-title":"Resting-state EEG connectivity at high-frequency bands and attentional performance dysfunction in stabilized schizophrenia patients","volume":"59","author":"Yeh","year":"2023","journal-title":"Med. (Kaunas., Lith. )"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825001434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825001434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T19:33:05Z","timestamp":1745695985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825001434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":83,"alternative-id":["S1043661825001434"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107718","relation":{},"ISSN":["1043-6618"],"issn-type":[{"type":"print","value":"1043-6618"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IUPHAR review: Computational Psychiatry 2.0. A new tool for supporting combination therapy of psychopharmacology with neuromodulation in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107718"}}